Email This Release
New Data for Darzalex®▼(daratumumab) Presented at ASH 2017 Show Feasibility of Subcutaneous Use and Potential of Darzalex as a Treatment for Smouldering Multiple Myeloma
*
marks required fields
Recipient Name:
*
Recipient Email:
Message:
*
Enter security words: